Skip to main content
Oncology Institute, Inc. logo

Oncology Institute, Inc. — Investor Relations & Filings

Ticker · TOI ISIN · US23343Q2093 US Human health and social work activities
Filings indexed 486 across all filing types
Latest filing 2026-04-28 Annual Report
Country US United States of America
Listing US TOI

About Oncology Institute, Inc.

https://theoncologyinstitute.com/

Oncology Institute, Inc. is a specialized oncology company that provides comprehensive, value-based cancer care within community settings. Operating a network of clinics and affiliate locations, the company focuses on delivering evidence-based medical oncology services. Its treatment offerings encompass a full spectrum of therapies, including high-precision radiation, chemotherapy, immunotherapy, targeted therapy, and hormone therapy. The institute's model emphasizes personalized, patient-centered care through its High-Value Cancer Care (HVCC) program, which addresses medical, emotional, and social needs. In addition to standard treatments, the company facilitates patient access to clinical trials for emerging therapies. The core mission is to enhance patient outcomes by providing advanced cancer care in convenient, local environments.

Recent filings

Filing Released Lang Actions
ARS - Oncology Institute, Inc. (0001799191) (Filer)
Annual Report
2026-04-28 English
4 - Oncology Institute, Inc. (0001799191) (Issuer)
Director's Dealing
2026-03-25 English
4 - Oncology Institute, Inc. (0001799191) (Issuer)
Director's Dealing
2026-03-23 English
3 - Oncology Institute, Inc. (0001799191) (Issuer)
Director's Dealing
2026-03-20 English
4 - Oncology Institute, Inc. (0001799191) (Issuer)
Director's Dealing
2026-03-18 English
4 - Oncology Institute, Inc. (0001799191) (Issuer)
Director's Dealing
2026-03-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.